Your only malignant mesothelioma news source!
Click on each item to read full story.

 
The Mesothelioma Compensation Center Urges Family Members of Diagnosed Victims of Malignant Mesothelioma to Take Wills ...
read story
WASHINGTON, Oct. 7, 2014 /PRNewswire/ -- The Mesothelioma Compensation Center is urging diagnosed victims of malignant mesothelioma or their family members to call them at 866-714-6466 as soon as possible after the actual diagnosis in order to ensure they have instant access to the nation's best mesothelioma compensation attorneys. This week the group is sharing a recent CNN Money article on the ...
 
Mesothelioma Compensation Center Urges Victims Of Mesothelioma To Call Them For Instant Access To The Nation's Best ...
read story
The Mesothelioma Compensation Center is urging just diagnosed victims of malignant mesothelioma or their family members to call them at 866-714-6466 for instant access to the nation's best mesothelioma compensation attorneys and a detailed conversation about vital issues that must be dealt with immediately, such as power of attorney. The group is focusing on how to write a will this week and ...
 
The Mesothelioma Victims Center Explains Mesothelioma and Why Proper Diagnosis Is Essential to Receiving Possible ...
read story
WASHINGTON, Oct. 17, 2014 /PRNewswire/ -- The Mesothelioma Victims Center says, "Every month we get at least a dozen calls from family members wondering if their deceased loved one could have had mesothelioma, and if there could be compensation without an actual diagnosis—the answer is no. If a medical doctor suggests mesothelioma is a possibility for a loved one, please call 866-714-6466 ...
 
Mesothelioma Compensation Center Responds to Recent Article, Addresses Issues Surrounding Future of Mesothelioma ...
read story
WASHINGTON, Oct. 20, 2014 /PRNewswire/ -- The Mesothelioma Compensation Center has been hearing from full-time mesothelioma compensation attorneys nationwide for about a year related to how much longer the mesothelioma compensation trusts will remain properly funded and is commenting on a recent article from the Huffington Post. The group discusses how the loss of funds may not impact current ...
 
Press Release
read story
Aduro BioTech Inc. a leader in cancer immunotherapy today announced that interim data from the Phase 1B clinical trial of its CRS-207 cancer immunotherapy in combination with chemotherapy as a front line treatment for malignant pleural mesothelioma will be presented at the International Mesothelioma Interest Group (iMig) Conference to be held in Cape Town South Africa October 21-24 2014.
 
Mesothelioma: New Findings On Treatment Options
read story
Treating patients with high-dose radiotherapy after chemotherapy and surgery for malignant pleural mesothelioma does not achieve improvements in local relapse and overall survival, according to new data from a prospective randomized phase II trial.
 
New Protein Study Could Mean Novel Treatment Option for Some Mesothelioma Patients, According to Surviving Mesothelioma
read story
Scientists say a protein that prevents the immune system from fighting cancer may be a new target for mesothelioma treatment. (PRWeb October 20, 2014) Read the full story at http://www.prweb.com/releases/2014/10/prweb12259711.htm
 
Aduro BioTech Announces Interim Phase 1B Clinical Data of CRS-207 for the Treatment of Mesothelioma Accepted for Oral ...
read story
BERKELEY, Calif.--(BUSINESS WIRE)--Aduro BioTech, Inc., a leader in cancer immunotherapy, today announced that interim data from the Phase 1B clinical trial of its CRS-207 cancer immunotherapy in combination with chemotherapy as a front line treatment for malignant pleural mesothelioma will be presented at the International Mesothelioma Interest Group (iMig) Conference to be held in Cape Town ...
 
PD-L1 protein could be a potential immunotherapy target for malignant pleural mesothelioma
read story
Treating patients with high-dose radiotherapy after chemotherapy and surgery for malignant pleural mesothelioma does not achieve improvements in local relapse and overall survival, according to data from a prospective randomized phase II trial presented at ESMO 2014 Congress in Madrid.
 
Mesothelioma Victims Center Provides US Citizens Who Had Heavy Exposure To Asbestos Decades With New Checklist Of ...
read story
“A checklist of mesothelioma symptoms is an extremely powerful tool to have access to, which is why we are providing families and victims of mesothelioma with the newest information this week,” says the Mesothelioma Victims Center. “Through educating these families with industry leading science and information behind this rare disease, we aim to extend the lives of as many victims as possible so ...